Domicile
Groupes
Pages
Marketplace
Plus
Groupes Pages Marketplace EvĂšnements Blogs Financement Offres Courses
Se connecter S’enregistrer
Mode nuit
đ”đ„đ­đšđŠđąđ«đąđŹ đƒđ«đźđ  đŒđšđ«đ€đžđ­ đ†đ«đšđ°đ­đĄ Innovations in Rare Disease Biologics
The Ultomiris Drug Market is experiencing significant growth due to the increasing prevalence of rare autoimmune and hematologic disorders, rising awareness about complement-mediated diseases, and advancements in biologic therapies. Ultomiris (ravulizumab), a long-acting complement C5 inhibitor, has emerged as a breakthrough treatment for several life-threatening conditions, driving...
0 Commentaires ·0 Parts ·298 Vue ·0 Aperçu
Connectez-vous pour aimer, partager et commenter!